Cadian Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-100,000
| Closed | -$12.4M | – | 34 |
|
|
2018
Q4 | $12.4M | Buy |
+100,000
| New | +$12.4M | 0.58% | 25 |
|
|
2018
Q3 | – | Sell |
-725,092
| Closed | -$125M | – | 30 |
|
|
2018
Q2 | $125M | Sell |
725,092
-486,497
| -40% | -$83.8M | 6.01% | 6 |
|
|
2018
Q1 | $183M | Sell |
1,211,589
-73,600
| -6% | -$11.1M | 9.88% | 2 |
|
|
2017
Q4 | $173M | Buy |
1,285,189
+106,241
| +9% | +$14.3M | 10.54% | 3 |
|
|
2017
Q3 | $172M | Sell |
1,178,948
-213,627
| -15% | -$31.2M | 8.07% | 4 |
|
|
2017
Q2 | $217M | Buy |
1,392,575
+173,812
| +14% | +$27M | 10.55% | 1 |
|
|
2017
Q1 | $177M | Sell |
1,218,763
-322,019
| -21% | -$46.7M | 8.46% | 1 |
|
|
2016
Q4 | $168M | Buy |
1,540,782
+229,490
| +18% | +$25M | 8.94% | 1 |
|
|
2016
Q3 | $159M | Buy |
1,311,292
+547,056
| +72% | +$66.5M | 8.4% | 2 |
|
|
2016
Q2 | $108M | Buy |
764,236
+290,000
| +61% | +$41M | 5.93% | 6 |
|
|
2016
Q1 | $61.9M | Sell |
474,236
-54,580
| -10% | -$7.13M | 4.16% | 7 |
|
|
2015
Q4 | $74.3M | Buy |
528,816
+200,141
| +61% | +$28.1M | 2.67% | 13 |
|
|
2015
Q3 | $43.7M | Buy |
328,675
+153,675
| +88% | +$20.4M | 1.57% | 16 |
|
|
2015
Q2 | $30.8M | Buy |
175,000
+65,000
| +59% | +$11.4M | 0.91% | 28 |
|
|
2015
Q1 | $19M | Buy |
+110,000
| New | +$19M | 0.51% | 38 |
|